TRUEX PAUL F 4
4 · CymaBay Therapeutics, Inc. · Filed Jan 26, 2018
Insider Transaction Report
Form 4
TRUEX PAUL F
Director
Transactions
- Award
Stock Option (right to buy)
2018-01-24+16,000→ 16,000 totalExercise: $11.69Exp: 2028-01-23→ Common Stock (16,000 underlying)
Footnotes (1)
- [F1]The option vests as to 1/12 of the underlying shares monthly beginning January 1, 2018.